Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Cellectis S.A. (CLLS)

« Back to company index

CLLS Chatter Timeline

Stock Ticker for CLLS

Most Active Tweeters for CLLS

UserTweets
@Gambiste1 4
@ConsumerFeed 4
@dailypoliticaln 4
@gcassidy718 3
@1MinuteStock 3

Recent Tweets for CLLS

TregCellRadar @TregCellRadar
@semodough @_B_I_O_T_E_C_H_ $allo?? $clls?? ?
January 19th 2020, 9:01am
TranscriptDaily @TranscriptDaily
Cellectis’ $CLLS “Buy” Rating Reiterated at William Blair https://t.co/kpQQadZ6d7
January 17th 2020, 7:01am
msmoneymoves @msmoneymoves
Here @MSMoneyMoves $CLLS has the following scores: - Financial Health Score: 15.11 (A rating) - Clinical Pipeline… https://t.co/bsD4b1EaaR
January 16th 2020, 8:01pm
AlertTrade @AlertTrade
RT @Briefingcom: $CLLS: Cellectis announces first patient dosing in AMELI-01 https://t.co/AGxK7biifm
January 15th 2020, 6:01pm
Briefingcom @Briefingcom
$CLLS: Cellectis announces first patient dosing in AMELI-01 https://t.co/AGxK7biifm
January 15th 2020, 6:01pm
Gambiste1 @Gambiste1
RT @biotechradar_eu: First Patient Dosed with Cellectis $ALCLS $CLLS’ New Allogeneic UCART123 Product Candidate for Relapsed/Refractory Acu…
January 15th 2020, 6:01pm
darksidetrader @darksidetrader
$CLLS First Patient Dosed with Cellectis’ New Allogeneic UCART123 Product Candidate for Relapsed/Refractory Acute Myeloid Leukemia
January 15th 2020, 5:01pm
biotechradar_eu @biotechradar_eu
First Patient Dosed with Cellectis $ALCLS $CLLS’ New Allogeneic UCART123 Product Candidate for Relapsed/Refractory… https://t.co/dOPD3NFaay
January 15th 2020, 4:01pm
otcdynamics @otcdynamics
$CLLS First Patient Dosed with Cellectis’ New Allogeneic UCART123 Product Candidate for Relapsed/Refractory Acute M https://t.co/5BG14mNvGX
January 15th 2020, 4:01pm
ThisLincolnian @ThisLincolnian
Cellectis $CLLS Stock Rating Reaffirmed by William Blair https://t.co/S1f9LGGRXy
January 15th 2020, 1:01am
TregCellRadar @TregCellRadar
@dhovekamp42 @AstellasUS Both $ALLO and $CLLS are already working on stem cell based CART. I'm not convinved they want/need another partner.
January 14th 2020, 7:01am
bbnsnews @bbnsnews
Cellectis’ $CLLS “Buy” Rating Reaffirmed at William Blair https://t.co/hXp9zQ43Ef
January 14th 2020, 6:01am
WatchlistN @WatchlistN
Short Interest in Cellectis SA $CLLS Decreases By 22.7% https://t.co/4RlTuMiIUV
January 13th 2020, 11:01pm
dispatchtribune @dispatchtribune
Short Interest in Cellectis SA $CLLS Decreases By 22.7% https://t.co/7xm2cRJ8R8
January 13th 2020, 11:01pm
AmericanBanking @AmericanBanking
Cellectis $CLLS Rating Reiterated by William Blair https://t.co/E1LAVGuoCJ #stocks
January 13th 2020, 8:01pm
ConsumerFeed @ConsumerFeed
Cellectis $CLLS Stock Rating Reaffirmed by William Blair https://t.co/iW7E0VQXko
January 13th 2020, 8:01pm
dailypoliticaln @dailypoliticaln
Cellectis $CLLS Stock Rating Reaffirmed by William Blair https://t.co/SZ4yyIfMKR
January 13th 2020, 8:01pm
IBD_AGatlin @IBD_AGatlin
Why this #biotech stock is planning to gene edit its cancer drugs $IOVA $CLLS #stocks #investingnews #geneediting https://t.co/V5VeyNKQx0
January 13th 2020, 3:01pm
gcassidy718 @gcassidy718
$CLLS Enjoy the weekend everyone! Cheers! ???? 5.66 % change recently https://t.co/Hry9HpLNxp
January 13th 2020, 4:01am
Gambiste1 @Gambiste1
RT @BehaviorFin: Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement $CLLS…
January 13th 2020, 4:01am
TradeTexasBig @TradeTexasBig
? $clls cc @dhovekamp42 https://t.co/bk4Y73bQ4w
January 12th 2020, 10:01pm
1MinuteStock @1MinuteStock
Wondering about #sentiment indicator for $CLLS? The Short Ratio is 3.13% https://t.co/vAUJQtnqsP
January 12th 2020, 9:01pm
1MinuteStock @1MinuteStock
Do you know that #Book Value for $CLLS is $8.03 https://t.co/hCClVLKfDW
January 12th 2020, 9:01pm
1MinuteStock @1MinuteStock
We calculated 21-day Expected Return of $CLLS for you: 23.97% https://t.co/xER53mRkyK
January 12th 2020, 8:01pm
syinvesting @syinvesting
Here’s some info on the TALEN technology that is the focus of the $IOVA / $CLLS collab. #GeneEditing… https://t.co/G3uK6WJUll
January 12th 2020, 8:01pm
Gambiste1 @Gambiste1
RT @bradloncar: $IOVA $CLLS deal is a good reminder that there are other editing tools out there besides CRISPR.
January 12th 2020, 6:01pm
HottestStockNow @HottestStockNow
$IOVA to Use TALEN Technology from $CLLS to Develop Gene-Edited Tumor Infiltrating Lymphocytes #IovanceBio… https://t.co/KdrHiG7mep
January 12th 2020, 6:01pm
OneMdcn @OneMdcn
RT @_B_I_O_T_E_C_H_: $IOVA Iovance will license certain #TALEN® technology from $CLLS Cellectis in order to develop tumor infiltrating lymp…
January 12th 2020, 6:01pm
newsfilterio @newsfilterio
Iovance in-licenses gene-editing technology from Cellectis $IOVA $CLLS https://t.co/YJRk5zM8fi
January 12th 2020, 5:01pm
SteelyRivers @SteelyRivers
$CLLS https://t.co/SBMA8zBYm2
January 12th 2020, 4:01pm
BIOTECH888 @BIOTECH888
RT @syinvesting: $IOVA & $CLLS enter into a research collaboration and exclusive WW license agreement whereby Iovance will license certain…
January 12th 2020, 4:01pm
BiotechObserver @BiotechObserver
RT @odibro: $IOVA $CLLS Enter into a Research Collaboration and Exclusive Worldwide License Agreement #JPM20 https://t.co/Hs68CE0Rtv
January 12th 2020, 4:01pm
otcdynamics @otcdynamics
$CLLS Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License https://t.co/kRACBuCvPN
January 12th 2020, 4:01pm
theswissfrank @theswissfrank
$IOVA and $CLLS Enter into a Research Collaboration and Exclusive Worldwide License Agreement #JPM2020 https://t.co/9KBeHS5Nwa
January 12th 2020, 4:01pm
syinvesting @syinvesting
$IOVA & $CLLS enter into a research collaboration and exclusive WW license agreement whereby Iovance will license c… https://t.co/vU6OPdQJFq
January 12th 2020, 4:01pm
bradloncar @bradloncar
$IOVA $CLLS deal is a good reminder that there are other editing tools out there besides CRISPR.
January 12th 2020, 4:01pm
odibro @odibro
$IOVA $CLLS Enter into a Research Collaboration and Exclusive Worldwide License Agreement #JPM20 https://t.co/Hs68CE0Rtv
January 12th 2020, 4:01pm
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
$IOVA Iovance will license certain #TALEN® technology from $CLLS Cellectis in order to develop tumor infiltrating l… https://t.co/0mkWIYhift
January 12th 2020, 4:01pm
dailypoliticaln @dailypoliticaln
Cellectis SA $CLLS Short Interest Update https://t.co/VHNZAILtD3
January 12th 2020, 2:01pm
AmericanBanking @AmericanBanking
Cellectis SA $CLLS Short Interest Update https://t.co/U4uQjOYk7q #stocks
January 12th 2020, 2:01pm
ConsumerFeed @ConsumerFeed
Cellectis SA $CLLS Short Interest Update https://t.co/2KsMFIFKv2
January 12th 2020, 2:01pm
ConsumerFeed @ConsumerFeed
Cellectis $CLLS Trading Up 5.7% https://t.co/vXA1mY9NsH
January 12th 2020, 11:01am
gcassidy718 @gcassidy718
$CLLS I'll have my bear burger medium rare with mushroom and swiss please. 5.66 % change recently https://t.co/Hry9HpLNxp
January 11th 2020, 2:01pm
dailypoliticaln @dailypoliticaln
Cellectis $CLLS and Cortexyme $CRTX Head to Head Survey https://t.co/91iN2Cwkk6
January 11th 2020, 3:01am
botpicks @botpicks
Should I Go Long or Short $CLLS ?
January 10th 2020, 7:01pm
MiniZin2 @MiniZin2
@gcassidy718 Mostly because it's under $40 where it should be trading. $CLLS they will get there this year...nice chart.
January 10th 2020, 3:01pm
portefeuillefun @portefeuillefun
Sold 0.2k $CLLS at $18.59, now 3k #vssporte shares.
January 10th 2020, 1:01pm
gcassidy718 @gcassidy718
$CLLS What happened??? why the bounce?? 4.85 % change recently https://t.co/Hry9HpLNxp
January 10th 2020, 12:01pm
TradeFlags @TradeFlags
#GoldenCross $CLLS at 17.32 R6 HiLo 69% T1Y 40 buy fwdPE -6.8 DIV N/A #Cellectis #stocks #trading #finance… https://t.co/QfbJu76h7I
January 9th 2020, 8:01pm
newsfilterio @newsfilterio
Cellectis: Monthly Information on Share Capital and Company Voting Rights $CLLS https://t.co/tFrr5dJcX7
January 9th 2020, 6:01pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.